Fate Therapeutics FATE
NASDAQ FATE
$2.32 +0.02 (+0.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Fate Therapeutics (FATE) Interest & Investment Income (2013 - 2026)

Updated

Fate Therapeutics (FATE) recorded Interest & Investment Income of $1.56 million in Q2 2026, down 46.8% from $2.92 million a year earlier and down 16.7% from the prior quarter.

Analysis

Fate Therapeutics (FATE) Interest & Investment Income (2013 - 2026) Analysis & Trends

On a TTM basis, Fate Therapeutics' Interest & Investment Income came in at $8.22 million as of Jun 30, 2026, down 43.6% year-over-year; for FY2025, it was $11.05 million, down 36.1% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 35.7% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $17.29 million in FY2024 (+0.6%), $17.19 million in FY2023 (+194.2%), $5.84 million in FY2022 (+346.3%) and $1.31 million in FY2021 (-45.5%).
  • The Q2 2026 figure is the lowest quarterly Interest & Investment Income since Q2 2022.
  • On a year-over-year basis, Interest & Investment Income has declined for eight consecutive quarters, with an average decline of 31.5% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 869.7% in Q4 2022, against a decline of 46.8% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.87 million (Q1 2026), $2.22 million (Q4 2025) and $2.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Fate Therapeutics 270.73 Mn 270.73 Mn - 1.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Mn
Mar 31, 2026 1.87 Mn
Dec 31, 2025 2.22 Mn
Sep 30, 2025 2.58 Mn
Jun 30, 2025 2.92 Mn
Mar 31, 2025 3.34 Mn
Dec 31, 2024 3.87 Mn
Sep 30, 2024 4.44 Mn
Jun 30, 2024 4.83 Mn
Mar 31, 2024 4.15 Mn
Dec 31, 2023 4.41 Mn
Sep 30, 2023 4.70 Mn
Jun 30, 2023 4.38 Mn
Mar 31, 2023 3.69 Mn
Dec 31, 2022 2.88 Mn
Sep 30, 2022 1.79 Mn
Jun 30, 2022 757,000.00
Mar 31, 2022 418,000.00
Dec 31, 2021 297,000.00
Sep 30, 2021 289,000.00
API Access

Fate Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=FATE&period=max&api_key=YOUR_API_KEY